115 related articles for article (PubMed ID: 14381226)
1. WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
SCHWAB RS; MARSHALL CK; TIMBERLAKE W
J Am Med Assoc; 1955 Jun; 158(8):625-8. PubMed ID: 14381226
[No Abstract] [Full Text] [Related]
2. [On anti-myasthenic activity of an oxamide derivative (Win 8077)].
GENTILI C; LOPERFIDO E
Arch Ital Sci Farmacol; 1959 Oct; 9():517-28. PubMed ID: 13827329
[No Abstract] [Full Text] [Related]
3. [Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
ALAJOUANINE T; CASTAIGNE P; BOURGUIGNON A; CAMBIER J
Therapie; 1958; 13(5):799-804. PubMed ID: 13625192
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of ambenonium (mysuran) chloride.
WESTERBERG MR
AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):91-4. PubMed ID: 13275166
[No Abstract] [Full Text] [Related]
5. In vitro activity of NN'-bis(diethylaminoethyl) oxamide bis benzyl-chloride (mytelase) on the cholinesterase of the electric organ of Electrophorus electricus, L.
LEMME CC; SOLLERO L; HARGREAVES AB
Arch Int Pharmacodyn Ther; 1959 Aug; 121():59-64. PubMed ID: 14415596
[No Abstract] [Full Text] [Related]
6. WIN 8077 in the treatment of sixty myasthenia gravis patients; a twelve-month report.
SCHWAB RS
Am J Med; 1955 Nov; 19(5):734-6. PubMed ID: 13268473
[No Abstract] [Full Text] [Related]
7. [New drug in the treatment of myasthenia gravis].
GRAVEL H; BEAUREGARD JM
Union Med Can; 1956 Jun; 85(6):681-5. PubMed ID: 13337985
[No Abstract] [Full Text] [Related]
8. Pyridostigmin (mestinon) in the treatment of myasthenia gravis.
SCHWAB RS; TIMBERLAKE WH
N Engl J Med; 1954 Aug; 251(7):271-2. PubMed ID: 13185412
[No Abstract] [Full Text] [Related]
9. Mestinon in the treatment of myasthenia gravis.
WESTERBERG MR; MAGEE KR
Neurology; 1954 Oct; 4(10):762-72. PubMed ID: 13214277
[No Abstract] [Full Text] [Related]
10. [Treatment of myasthenia gravis with pyridostigmine (mestinon)].
BARRAQUER-BORDAS L; PONCESVERGE J
Rev Clin Esp; 1955 Aug; 58(4):236-43. PubMed ID: 13281050
[No Abstract] [Full Text] [Related]
11. Treatment of myasthenia gravis with prolonged-action mestinon.
MAGEE KR; WESTERBERG MR
Neurology; 1959 May; 9(5):348-51. PubMed ID: 13657293
[No Abstract] [Full Text] [Related]
12. [First therapeutic results with mytelase (mysuran, win 8077) in myasthenia].
DESMEDT JE
Acta Neurol Psychiatr Belg; 1957 Feb; 57(2):94-103. PubMed ID: 13424193
[No Abstract] [Full Text] [Related]
13. [A new drug for myasthenia gravis].
RAVINA A
Presse Med (1893); 1955 Oct; 63(65):1329. PubMed ID: 13280621
[No Abstract] [Full Text] [Related]
14. Treatment of myasthenia gravis with mestinon bromide.
TETHER JE
J Am Med Assoc; 1956 Jan; 160(3):156-8. PubMed ID: 13278161
[No Abstract] [Full Text] [Related]
15. [Mestinon, a new remedy for myasthenia gravis].
LONNUM A
Tidsskr Nor Laegeforen; 1955 Aug; 75(16):581-2. PubMed ID: 13267868
[No Abstract] [Full Text] [Related]
16. Report of a case of myasthenia gravis.
BRYAN FA
J Indiana State Med Assoc; 1956 Mar; 49(3):257-8. PubMed ID: 13306994
[No Abstract] [Full Text] [Related]
17. MYASTHENIA gravis.
Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
[No Abstract] [Full Text] [Related]
18. [Current trends in medical and surgical treatment of myasthenia gravis with persistence of the thymus and long-term results of some operated cases].
Sunseri S; Sottosanti M; Spinelli P
Arch Chir Torac Cardiovasc; 1970; 26(1):19-34. PubMed ID: 5477673
[No Abstract] [Full Text] [Related]
19. Pyridostigmine (mestinon) in myasthenia gravis; a case report.
POLLITZER RS
J S C Med Assoc; 1956 Feb; 52(2):46-7. PubMed ID: 13286785
[No Abstract] [Full Text] [Related]
20. The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
GUINENA YH; NABI SA; TAHER Y
J Egypt Med Assoc; 1956 Jun; 39(3):240-51. PubMed ID: 13367321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
